Caricamento...

SAT-493 A Case of Profound Hypothyroidism Secondary to Immune Check Point Inhibitors

Background: The discovery of immune check-point inhibitors (ICI) revolutionized cancer treatment. CTLA-4, anti-PD-1 and anti-PD-L1 monoclonal antibodies have been approved in recent years. However, the advantageous clinical outcomes can also be associated with potentially severe immune related adver...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Endocr Soc
Autori principali: Tun, Yin Nwe, Rodriguez, Giovanna, Bahtiyar, Gul
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7209753/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.694
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !